What is NDC 42385-962?

42385-962 is the product NDC for Abacavir and Lamivudine, Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 tablet, film coated, listed with the FDA by Laurus Labs Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Laurus Labs Limited, NDC labeler code 42385. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Abacavir and Lamivudine?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Abacavir and Lamivudine NDC 42385-962

NDC codes

FDA NDC Directory

Product NDC (as listed)42385-962Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42385-0962Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42385-962-18	4238509621842385096218	180 TABLET, FILM COATED in 1 BOTTLE (42385-962-18)Marketed from Jul 25, 2022
42385-962-30	4238509623042385096230	30 TABLET, FILM COATED in 1 BOTTLE (42385-962-30)Marketed from Jul 25, 2022
42385-962-90	4238509629042385096290	90 TABLET, FILM COATED in 1 BOTTLE (42385-962-90)Marketed from Jul 25, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abacavir and Lamivudine
Generic name (nonproprietary): abacavir and lamivudine
Active ingredients: Abacavir sulfate — 600 mg/1Lamivudine — 300 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Laurus Labs LimitedNDC labeler code 42385
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216332
Marketing start: Jul 25, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
Identifiers: Product ID 42385-962_6ce5a446-f6a1-4efe-8a69-fd6ddf1a8ab2SPL ID 6ce5a446-f6a1-4efe-8a69-fd6ddf1a8ab2
Pharmacologic class: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442385096218 followed by a unit qualifier and the quantity

Package 42385-0962-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 42385-962

What is NDC 42385-962?: 42385-962 is the product NDC for Abacavir and Lamivudine, Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1 tablet, film coated, listed with the FDA by Laurus Labs Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Abacavir and Lamivudine.
What is the active ingredient?: Abacavir sulfate, Lamivudine.
Who is the labeler?: Laurus Labs Limited, NDC labeler code 42385. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abacavir and Lamivudine?: 5 other product NDCs are listed under this name. See all Abacavir and Lamivudine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abacavir and Lamivudine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ABACAVIR and LAMIVUDINE	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-838	31722-0838-30
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-440	33342-0440-0733342-0440-1433342-0440-98
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-335	65862-0335-1065862-0335-30
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-288	—
Abacavir and Lamivudine	Abacavir sulfate 600 mg/1; Lamivudine 300 mg/1	Tablet, Film coatedOral	Cipla USA Inc.	69097-362	69097-0362-02